Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.10.22.761185

Technology solutions for immune loci: integrated high-resolution KIR genotyping reveals allelic, structural, and KIR-HLA diversity across 24 human populations

Abstract

High-resolution genotyping of killer cell immunoglobulin-like receptor (KIR) genes remains challenging because of extensive sequence homology, copy-number variation, and complex haplotype structures. Although KIR allelic variation influences receptor expression and function, routine typing has largely been limited to gene presence or absence. Here, we evaluated an integrated short-read sequencing system combining a four-reaction, two-stage multiplex PCR assay (ScisGo-KIR-v3), centralized cloud-based copy-aware allele analysis, and interactive genotype review. The system was applied to 2,298 individuals representing 24 populations from the 1000 Genomes Project, with matched high-resolution HLA class I genotypes. Independent validation against complete, phased PacBio KIR sequences from 48 samples demonstrated 98.6% automated copy-number concordance and 92.8% combined copy-number and allele concordance across 768 gene-sample comparisons. Following desktop review, all evaluated assignments were concordant with the reference sequences. In a separate comparison of four computational genotyping methods involving 311 shared samples, the automated Scisco pipeline showed the lowest overall mismatch with the four-method consensus (1.62%). Population analyses identified substantial allele diversity and distinct centromeric and telomeric haplotype-motif distributions. Although exact haplotype pairs were frequently ambiguous, structural assignments became increasingly resolvable at the motif level, and motif backgrounds exhibited characteristic allele compositions. Paired KIR and HLA analysis revealed inherited receptor-ligand configurations concealed by gene-content typing. Among 1,401 KIR3DL1/HLA-B Bw4 co-carriers, 57 lacked an allele annotated for ordinary surface expression, while 457 of 1,175 KIR2DS4 co-carriers of six specified HLA-C allotypes carried only truncated receptor forms. Allele-specific KIR2DL1 and KIR2DS5 classifications further distinguished receptor properties and published ligand-binding annotations that varied among populations. Although potential receptor-ligand repertoire composition differed across populations, analyses did not establish preferential KIR-HLA genetic association after accounting for population structure and multiple testing. Together, these findings demonstrate that integrated short-read KIR genotyping can provide scalable, high-resolution allele and copy-number information while explicitly retaining uncertainty in inferred haplotype structures. Compatibility with established HLA laboratory workflows provides a practical foundation for incorporating allele-resolved KIR analysis into immunogenetic research and future clinical investigations.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Pyo, C.-W., Wang, R., Thomas, A., Song, Y., Friedman, C., Ohm, Y., Ishitani, A., Nelson, W. C., Geraghty, D. E.. 2026-10-27. Technology solutions for immune loci: integrated high-resolution KIR genotyping reveals allelic, structural, and KIR-HLA diversity across 24 human populations. https://doi.org/10.64898/2026.10.22.761185

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Alzheimer's disease-associated rs28834970 variant in PTK2B impairs electrical activity and regulates Tau phosphorylation and APP processing in human neuronal cultures

Background: Genome-wide association studies have identified the PTK2B gene, which encodes Proline-rich tyrosine kinase 2 (PYK2), as a genetic risk factor for Alzheimer's disease (AD). However, its role in AD aetiology remains to be understood, as a complex contribution to amyloid {beta} (A{beta}) toxicity, tauopathy and neuronal dysfunction is suggested by contradictory evidence. Determining how the causal variant among AD-associated PTK2B variants impairs PYK2 function to trigger AD hallmarks could bring clarification. Methods: We combined in silico prediction tools with luciferase reporter assays in neuroblastoma cells to prioritize potential AD-associated PTK2B functional variants. We generated isogenic KOLF2.1J induced pluripotent stem cells (iPSCs) carrying the most relevant functional variant using CRISPR-Cas9 and differentiated them into human neuronal cultures (hNCs). We assessed PYK2 expression via immunoblotting, performed transcriptomic profiling using RNA-sequencing, analyzed neuronal network activity via multielectrode array (MEA) recordings, quantified synaptic density through immunocytochemistry in microfluidic devices, and assessed Tau phosphorylation and amyloid-precursor protein (APP) metabolism. Results: The rs28834970 regulatory variant was identified as the most functionally relevant in our model, with the C risk allele promoting transcription factor C/EBP{beta} binding within a cis-regulatory element. In hNCs, the homozygous rs28834970 CC genotype reduced total PYK2 levels by more than 80%, while increasing the proportion of phosphorylated (activated) PYK2. Transcriptomic analysis revealed 724 downregulated and 113 upregulated gene sets, with altered expression of genes involved in extracellular matrix organization, cytoplasmic translation and neurotransmitter secretion. MEA recordings showed reduced network recruitment and altered burst organization. Immunocytochemistry in microfluidic devices consistently revealed that rs28834970 impacts dendritic development and postsynaptic maturation. The risk genotype significantly elevated Tau phosphorylation at pathological sites (Thr181, Thr217, Thr231, Ser202-Thr205, Ser396-Ser404), and enhanced APP processing, resulting in decreased levels of APP and CTF but increased levels of sAPP, sAPP{beta} and A{beta}. Conclusion: The rs28834970 C risk allele mechanistically links AD susceptibility to downregulation of PTK2B/PYK2 expression and to the increase in Tau pathology and A{beta} levels while compromising synaptic structure and function.

genetics↗

Human infection with an ape Plasmodium vivax-like parasite

An unusually divergent Plasmodium vivax parasite was reported in a Swedish patient with recent travel. Using whole-genome sequencing, we show that the infection was caused by a strain of ape P. vivax-like, providing evidence of the zoonotic potential of these parasites that infect wild gorillas and chimpanzees in central Africa.

genetics↗

Preclinical Development and Safety of Laterally Spreading Dual AAV.SPR-MYO7A Vectors for the Treatment of Usher Syndrome Type 1B

Usher syndrome type 1B (USH1B), caused by mutations in MYO7A, is the most severe form of Usher syndrome and accounts for more than 50% of USH1 cases. Affected patients are born profoundly deaf with vestibular dysfunction and develop progressive retinitis pigmentosa, for which no approved treatment exists. The MYO7A coding sequence exceeds the packaging capacity of adeno-associated virus (AAV), the gold standard vector for retinal gene therapy. To overcome this, we developed dual AAV hybrid and overlap platforms to reconstitute full-length MYO7A expression in photoreceptors and retinal pigment epithelium. Modification of cDNA split points, and reduction of non-coding sequence yielded optimized vector pairs that produced higher full-length MYO7A levels with substantially reduced truncated protein. Packaging in the laterally spreading AAV.SPR capsid enabled supraphysiological MYO7A expression in cynomolgus macaques at macular and distal retinal sites without requiring foveal detachment, an important safety consideration for USH1B patients with remaining central vision. A six-month GLP toxicology study confirmed that ATSN-301, an AAV.SPR-based dual vector reconstituting MYO7A driven by the smCBA promoter, was well tolerated at all doses, with a No Observed Adverse Effect Level established at 1.2E11 vg/eye, supporting its clinical advancement for USH1B.

genetics↗